Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews.com

Equities researchers at StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued to investors on Sunday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of CALA opened at $0.01 on Friday. The stock’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.01. Calithera Biosciences has a 12 month low of $0.00 and a 12 month high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.